Impact of local endothelial challenge with cytomegalovirus or glycoprotein B on vasodilation in intact pressurized arteries from nonpregnant and pregnant mice

Biology of Reproduction

Volumn 87, Issue 4, 2012, Pages

  Gombos, Randi B ^a   Teefy, Jana ^a   Lee, Albert ^a   Hemmings, Denise G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cytomegalovirus; Glycoprotein B; Methacholine; Pregnancy; Vasodilation

Indexed keywords

GLYCOPROTEIN B; METHACHOLINE; PROSTAGLANDIN; THROMBOXANE RECEPTOR; THROMBOXANE RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; MESENTERIC ARTERY; MOUSE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; UTERINE ARTERY; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIAL CELLS; FEMALE; GESTATIONAL AGE; MALE; MESENTERIC ARTERIES; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REGIONAL BLOOD FLOW; UTERINE ARTERY; UTERUS; VASOCONSTRICTOR AGENTS; VASODILATION; VIRAL ENVELOPE PROTEINS;

CYTOMEGALOVIRUS; MUS;

EID: 84869419978     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.112.099168     Document Type: Article

References (42)

1. Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991; 13:315-329.
2. Prosch S, Wendt CE, Reinke P, Priemer C, Oppert M, Kruger DH, Volk HD, Docke WD. A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation.Virology 2000; 272:357-365.
3. Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 2004; 110:207-212.
4. Fernando S, Pearce JM, Booth JC. Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus. J Med Virol 1993; 41:108-113.
5. Sweet C. The pathogenicity of cytomegalovirus. FEMS Microbiol Rev 1999; 23:457-482.
6. Persoons MC, Stals FS, van dam Mieras MC, Bruggeman CA. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J Pathol 1998; 184:103-109.
7. Grahame-Clarke C. Human cytomegalovirus, endothelial function and atherosclerosis. Herpes 2005; 12:42-45.
8. von Dadelszen P, Magee LA, Krajden M, Alasaly K, Popovska V, Devarakonda RM, Money DM, Patrick DM, Brunham RC. Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG 2003; 110:725-730.
9. Carreiras M, Montagnani S, Layrisse Z. Preeclampsia: a multifactorial disease resulting from the interaction of the feto-maternal HLA genotype and HCMV infection. Am J Reprod Immunol 2002; 48:176-183.
10. Gombos RB, Hemmings DG. Differential effects on nitric oxide-mediated vasodilation in mesenteric and uterine arteries from cytomegalovirusinfected mice. Am J Physiol Heart Circ Physiol 2010; 299:H1124-H1134.
11. Gombos RB, Wolan V, McDonald K, Hemmings DG. Impaired vascular function in mice with an active cytomegalovirus infection. Am J Physiol Heart Circ Physiol 2009; 296:H937-H945.
12. Evers DL, Wang X, Huang ES. Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect 2004; 6: 1084-1093.
13. Fortunato EA, McElroy AK, Sanchez I, Spector DH. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 2000; 8:111-119.
14. Zhu H, Cong JP, Mamtora G, Gingeras T, Shenk T. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A 1998; 95:14470-14475.
15. Lopper M, Compton T. Disulfide bond configuration of human cytomegalovirus glycoprotein B. J Virol 2002; 76:6073-6082.
16. Compton T. Receptors and immune sensors: the complex entry path of human cytomegalovirus. Trends Cell Biol 2004; 14:5-8.
17. Isaacson MK, Compton T. Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress. J Virol 2009; 83:3891-3903.
18. Bender FC, Whitbeck JC, Lou H, Cohen GH, Eisenberg RJ. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J Virol 2005; 79:11588-11597.
19. Bernstein DI, Schleiss MR, Berencsi K, Gonczol E, Dickey M, Khoury P, Cadoz M, Meric C, Zahradnik J, Duliege AM, Plotkin S. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults. J Infect Dis 2002; 185:686-690.
20. Schleiss MR, Bourne N, Stroup G, Bravo FJ, Jensen NJ, Bernstein DI. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J Infect Dis 2004; 189:1374-1381.
21. Endresz V, Kari L, Berencsi K, Kari C, Gyulai Z, Jeney C, Pincus S, Rodeck U, Meric C, Plotkin SA, Gonczol E. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization. Vaccine 1999; 17:50-58.
22. Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, Cloud G. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 360:1191-1199.
23. Isaacson MK, Feire AL, Compton T. Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J Virol 2007; 81:6241-6247.
24. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 2003; 424:456-461.
25. Wang X, Huang DY, Huong SM, Huang ES. Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Nat Med 2005; 11:515-521.
26. Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Fruh K. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A 2001; 98:7140-7145.
27. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003; 77:4588-4596.
28. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009; 78:539-552.
29. Pass RF. Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant. J Clin Virol 2009; 46(suppl 4):S73-S76.
30. Presti RM, Pollock JL, Dal Canto AJ, ÓGuin AK, Virgin HW IV. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 1998; 188:577-588.
31. Tanaka A, Hirota K, Takahashi K, Numazaki Y. Suppression of cell mediated immunity to cytomegalovirus and tuberculin in pregnancy employing the leukocyte migration inhibition test. Microbiol Immunol 1983; 27:937-943.
32. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, Mocarski ES. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 1994; 68:6243-6253.
33. Walton SM, Wyrsch P, Munks MW, Zimmermann A, Hengel H, Hill AB, Oxenius A. The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol 2008; 181:1128-1134.
34. Osol G, Celia G, Gokina N, Barron C, Chien E, Mandala M, Luksha L, Kublickiene K. Placental growth factor is a potent vasodilator of rat and human resistance arteries. Am J Physiol Heart Circ Physiol 2008; 294:H1381-H1387.
35. Veerareddy S, Cooke CL, Baker PN, Davidge ST. Vascular adaptations to pregnancy in mice: effects on myogenic tone. Am J Physiol Heart Circ Physiol 2002; 283:H2226-H2233.
36. Mocarski ES. Cytomegaloviruses and their replication In: Fields BN,, Knipe DM, Howley PM (eds.), Fields Virology. Philadelphia: Lippincott- Raven; 1996:2447-2492.
37. Britt WJ, Vugler L, Butfiloski EJ, Stephens EB. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMVrecombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J Virol 1990; 64:1079-1085.
38. Bonventre JV. Phospholipase A2 and signal transduction. J Am Soc Nephrol 1992; 3:128-150.
39. Yinon Y, Farine D, Yudin MH, Gagnon R, Hudon L, Basso M, Bos H, Delisle MF, Menticoglou S, Mundle W, Ouellet A, Pressey T, et al. Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can 2010; 32:348-354.
40. Sharma JN. Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system. Arch Med Res 2006; 37:299-306.
41. Rabelo ER, Rohde LE, Schaan BD, Rubira MC, Ruschel KB, Plentz RD, Consolim-Colombo FM, Irigoyen MC, Moreno Júnior H. Bradykinin or acetylcholine as vasodilators to test endothelial venous function in healthy subjects. Clinics (Sao Paulo) 2008; 63:677-682.
42. Dickey RP. Doppler ultrasound investigation of uterine and ovarian blood flow in infertility and early pregnancy. Hum Reprod Update 1997; 3: 67-503.